Skip to content
Menu

Nephros, Inc. NEPH

Full chart Compare
Set alert

Price alert · NEPH

All alert types
2.84 USD -0.05 (-1.73%)

Regular-session close

2.90 +0.06 +2.11%

After hours · Nov 19, 7:41 PM ET

2.82 Day range 2.99
2.78 52-week range 5.79
YTD
-41.80%
1 year
-43.54%

5D +0.01 (+0.33%)

33.203.40MonTueWedThuFri3.05
Market cap
30.87M
Revenue (ttm)
13.77M
Profit margin
-9.40%
EPS (ttm)
0.17
Shares out
10.54M
P/E ratio
16.71
Forward P/E
148.50
YTD return
-41.80%
1-year return
-43.54%
Volume
56.02K
Avg volume
48.94K
Open
2.99
Previous close
2.89
Day's range
2.82 – 2.99
52-week range
2.78 – 5.79
Beta
1.19
Price target
4.75 (+67.3%)
50-day average
1.52

Key statistics

200-day average
1.93
Enterprise value
14.84M
Price / sales
1.14
Price / book
1.87
Revenue growth
-8.30%
Free cash flow
-235.88K
Total cash
3.08M
Total debt
1.58M
Return on equity
-15.61%
Short % of float
0.01%

Fundamental scorecard

14 of 25 checks passed on NEPH’s reported financials

ValueGrowthProfitabilityHealthDividend

14of 25 checks passed

  • Value 3 of 5
  • Growth 4 of 5
  • Profitability 3 of 5
  • Financial health 4 of 5
  • Dividend 0 of 5

Statements to Sep 30, 2026.

Financials — quick view

All financials
NEPH Revenue — quarterly 5.62M
NEPH Net income — quarterly 512.00K
NEPH EPS — quarterly 0.05

Earnings

NEPH recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 7, 2024Sep 1, 20240.000.02——
Aug 8, 2024Jun 1, 20240.00-0.03——
May 9, 2024Mar 1, 20240.00-0.02——
Mar 7, 2024Dec 1, 20230.00-0.06——
Nov 8, 2023Sep 1, 20230.00-0.02——
Aug 9, 2023Jun 1, 20230.00-0.04——

Upgrades / downgrades

NEPH analyst upgrades and downgrades
DateFirmActionFromTo
Nov 12, 2024BenchmarkreitSpeculative BuySpeculative Buy
May 15, 2024BenchmarkreitSpeculative BuySpeculative Buy
Mar 8, 2024BenchmarkupHoldSpeculative Buy
Jan 26, 2021B. Riley Securitiesinit—Buy
Oct 24, 2019Benchmarkinit—Speculative Buy
Oct 4, 2019Maxim Groupinit—Buy

About Nephros, Inc.

Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water, as well as reduce biofilm, cysts, particulates, and scale build-up in downstream equipment. It markets its products to food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.

Sector
Healthcare
Industry
Medical Instruments & Supplies
Country
United States
Website
nephros.com

News

Your note

Sign in to keep a note on NEPH — it syncs with the Stock Master app.

Insider holders

NEPH insider holders
InsiderRelationLatest transactionDateShares held
AMRON ARTHUR HDirectorPurchaseMay 29, 2024103,463
BANKS ROBERT R JR.Chief Executive OfficerPurchaseMay 15, 202470,000
GWYDIR TOMDirectorStock Award(Grant)Jan 4, 202343,226
HARRIS JOSEPH MICHAELDirectorStock Award(Grant)Dec 12, 202317,693
LASK ALISADirectorStock Award(Grant)Dec 12, 202348,629
SPANDOW OLIVER JDirectorStock Award(Grant)Dec 12, 202381,604

Institution ownership

NEPH institution ownership
Holder% heldSharesValueReported
Wexford Capital LP46.93%3,600,5525.35MSep 29, 2024
Vanguard Group Inc2.63%201,994299.96KSep 29, 2024
Bard Associates Inc.2.25%172,371255.97KSep 29, 2024
Geode Capital Management, LLC1.11%85,249126.59KSep 29, 2024
HighTower Advisors, LLC0.75%57,21084.96KSep 29, 2024
Blair (William) & Company, L.L.C.0.47%36,24953.83KSep 29, 2024

Fund ownership

NEPH fund ownership
Holder% heldSharesValueReported
Vanguard Total Stock Market Index Fund1.69%129,656192.54KSep 29, 2024
Vanguard Extended Market Index Fund0.94%72,338107.42KSep 29, 2024
Fidelity Extended Market Index Fund0.72%54,91381.55KOct 30, 2024
Fidelity Series Total Market Index Fund0.18%14,10620.95KOct 30, 2024
Fidelity Total Market Index Fund0.11%8,13612.08KOct 30, 2024
Dimensional ETF Tr-Dimensional US Core Equity 1 ETF0.07%5,0007.42KJul 30, 2024